Postmarketing safety of loratinib: An analysis of the FDA Adverse Event Reporting System (FAERS).

Authors: Yaning Zhu, Jianhua Wang, Yi Liu

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e24103

Source: Full article

Abstract

e24103